康希諾生物2024上半年業績亮眼：流腦疫苗引領增長，加快合作與國際化步伐
Aug 29, 2024 22:17 HKT | |
|
康希诺生物2024上半年业绩亮眼：流脑疫苗引领增长，加快合作与国际化步伐
Aug 29, 2024 22:10 HKT | |
|
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna's COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1
Aug 24, 2024 08:00 HKT |  |
|
日本厚生劳动省批准了莫德纳公司针对SARS-COV-2 JN.1变异株的COVID-19 mRNA疫苗的部分变更申请
Aug 24, 2024 08:00 HKT | |
|
日本厚生勞動省批准了莫德納公司針對SARS-COV-2 JN.1變異株的COVID-19 mRNA疫苗的部分變更申請
Aug 24, 2024 08:00 HKT | |
|
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024
Aug 23, 2024 08:00 HKT |  |
|
乐普生物公布2024年中期业绩 ADC管线取得重大进展 核心产品营收大增一倍
Aug 22, 2024 11:59 HKT |  |
|
樂普生物公佈2024年中期業績 ADC管線取得重大進展 核心產品營收大增一倍
Aug 22, 2024 11:35 HKT | |
|
亚洲公司突破Ac-225制备关键技术
Aug 15, 2024 20:00 HKT |  |
|
亞洲公司突破Ac-225製備關鍵技術
Aug 15, 2024 20:00 HKT | |
|
Sino Biopharmaceutical (1177.HK) Announces 2024 Interim Results
Aug 14, 2024 00:30 HKT |  |
|
中国生物制药（1177.HK）公布2024中期业绩
Aug 14, 2024 00:10 HKT | |
|
中國生物製藥（1177.HK）公佈2024中期業績
Aug 14, 2024 00:01 HKT | |
|
2024 CSE - 君聖泰醫藥分享天然產物在代謝性疾病的創新成果
Aug 12, 2024 17:55 HKT |  |
|
2024 CSE | 君圣泰医药分享天然产物在代谢性疾病的创新成果
Aug 12, 2024 17:32 HKT | |
|
Q&M Dental Group's profit after tax grew 84%, Board declared 0.40 cent interim dividend, a 150% increase over the same period last year
Aug 12, 2024 15:00 HKT |  |
|
Dual-action therapy shows promise against aggressive oral cancer
Jul 30, 2024 20:00 HKT |  |
|
Avance Clinical 任命亚洲区域总监，作为全球扩展计划的一部分
Jul 24, 2024 08:00 HKT |  |
|
Avance Clinical 任命亞洲區域總監，作為全球擴展計畫的一部分
Jul 24, 2024 08:00 HKT | |
|
Avance Clinical, 글로벌 확장 프로그램의 일환으로 아시아 지역 이사 임명
Jul 24, 2024 08:00 HKT | |
|